Medy-Tox Inc. (086900.KQ)

KRW 124900.0

(-2.42%)

Long Term Debt Summary of Medy-Tox Inc.

  • Medy-Tox Inc.'s latest annual long term debt in 2023 was 1.22 Billion KRW , down -93.87% from previous year.
  • Medy-Tox Inc.'s latest quarterly long term debt in 2024 Q2 was - KRW , down 0.0% from previous quarter.
  • Medy-Tox Inc. reported annual long term debt of 20 Billion KRW in 2022, down -63.67% from previous year.
  • Medy-Tox Inc. reported annual long term debt of 55.05 Billion KRW in 2021, down -15.64% from previous year.
  • Medy-Tox Inc. reported quarterly long term debt of - KRW for 2024 Q2, down 0.0% from previous quarter.
  • Medy-Tox Inc. reported quarterly long term debt of 1.22 Billion KRW for 2023 Q4, down -75.48% from previous quarter.

Annual Long Term Debt Chart of Medy-Tox Inc. (2023 - 2012)

Historical Annual Long Term Debt of Medy-Tox Inc. (2023 - 2012)

Year Long Term Debt Long Term Debt Growth
2023 1.22 Billion KRW -93.87%
2022 20 Billion KRW -63.67%
2021 55.05 Billion KRW -15.64%
2020 65.26 Billion KRW 36597.64%
2019 177.83 Million KRW 0.0%
2018 - KRW -100.0%
2017 15 Billion KRW -75.71%
2016 61.75 Billion KRW 0.0%
2015 - KRW 0.0%
2014 - KRW 0.0%
2013 - KRW -100.0%
2012 2.09 Billion KRW 0.0%

Peer Long Term Debt Comparison of Medy-Tox Inc.

Name Long Term Debt Long Term Debt Difference
HLB Co., Ltd. 17.93 Billion KRW 93.164%
iNtRON Biotechnology, Inc. 258.29 Million KRW -374.59%
BINEX Co., Ltd. 5.57 Billion KRW 78.025%
Bioneer Corporation 12.5 Billion KRW 90.193%
Anterogen.Co.,Ltd. - KRW -Infinity%
MEDIPOST Co., Ltd. 6.99 Billion KRW 82.475%
CrystalGenomics, Inc. 29.88 Billion USD 95.899%
Helixmith Co., Ltd 151.68 Million KRW -708.176%
Chabiotech Co.,Ltd. 95.06 Billion KRW 98.711%
Peptron, Inc. 4.5 Billion KRW 72.759%
Amicogen, Inc. 70.65 Billion KRW 98.265%
Genexine, Inc. 22.68 Billion KRW 94.595%
HLB Therapeutics Co.,Ltd. 1.84 Billion KRW 33.385%
LegoChem Biosciences, Inc. 528.37 Million KRW -132.003%
ALTEOGEN Inc. 1.24 Billion KRW 1.874%
PharmaResearch Co., Ltd. 970.71 Million KRW -26.282%
SillaJen, Inc. 8.13 Billion KRW 84.933%
JETEMA, Co., Ltd. 60 Billion KRW 97.957%
OliX Pharmaceuticals,Inc 35.36 Billion KRW 96.533%
Genomictree Inc. 97.51 Million KRW -1157.072%
MedPacto, Inc. 1.68 Billion KRW 27.334%
D&D Pharmatech 5.12 Billion KRW 76.061%
EASY BIO,Inc. 30 Billion KRW 95.914%
GI Innovation, Inc. 2.9 Billion KRW 57.788%